Primus Pharmaceuticals recalls
FDA enforcement reports naming Primus Pharmaceuticals, Inc. as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 4
- Most recent report
- Feb 21, 2018
- Feb 21, 2018Limbrel (flavocoxid 500 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primu…Drug · Primus Pharmaceuticals, Inc.Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.Class I
- Feb 21, 2018Limbrel (flavocoxid 250 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primu…Drug · Primus Pharmaceuticals, Inc.Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.Class I
- Feb 21, 2018Limbrel250 (flavocoxid and citrated zinc bisglycinate) 250 mg/50 mg capsules, 60-count…Drug · Primus Pharmaceuticals, Inc.Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.Class I
- Feb 21, 2018Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count…Drug · Primus Pharmaceuticals, Inc.Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.Class I